Hangzhou AGS MedTech Co. Ltd. A (688581) — Cash Flow Reinvestment Rate
Hangzhou AGS MedTech Co. Ltd. A (688581) has a Cash Flow Reinvestment Rate of 0.42x as of December 2025, reinvesting CN¥63.47 Million (capex CN¥63.47 Million ) from operating cash flow of CN¥151.20 Million. See 688581 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hangzhou AGS MedTech Co. Ltd. A Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Hangzhou AGS MedTech Co. Ltd. A across 5 annual periods. For the full cash flow conversion analysis, see 688581 operating cash flow.
Annual Cash Flow Reinvestment Rate for Hangzhou AGS MedTech Co. Ltd. A (2021–2025)
Year-by-year capital reinvestment analysis for Hangzhou AGS MedTech Co. Ltd. A. See financial agility of Hangzhou AGS MedTech Co. Ltd. A to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CN¥63.47 Million | CN¥151.20 Million | CN¥63.47 Million | ▲ +167.2% |
| 2024 | 0.16x | CN¥49.60 Million | CN¥315.80 Million | CN¥49.60 Million | ▼ -32.6% |
| 2023 | 0.23x | CN¥51.57 Million | CN¥221.45 Million | CN¥51.57 Million | ▼ -39.4% |
| 2022 | 0.38x | CN¥60.12 Million | CN¥156.38 Million | CN¥60.12 Million | ▲ +179.0% |
| 2021 | 0.14x | CN¥16.29 Million | CN¥118.25 Million | CN¥15.66 Million | — |